SAMEER VEERANI: Open Payments
NPI 1457807802 · EULESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 79 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $402 · 2025 $1,687
Food & beverage: $1,592Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $702 |
| Janssen Biotech, Inc. | 14 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $129 |
| GENZYME CORPORATION | 4 | $125 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Intercept Pharmaceuticals, Inc. | 4 | $99 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| Aimmune Therapeutics, Inc. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
Products named: RINVOQ, TREMFYA, DUPIXENT, GIMOTI, CREON, OCALIVA, IQIRVO, ZENPEP.
Industry payments across TX — which companies pay providers there.
